Tag: eteplirsen

Novartis’ Aimovig leads CHMP recommendations

by Selina McKee | Jun 4, 2018 | News | 0

The European Medicines Agency’s Committee for Medicinal Products for Human Use has endorsed nine medicines for approval at its May meeting, including Novartis’ Aimovig, the first human monoclonal antibody for migraine prevention.

FDA OKs first Duchenne muscular dystrophy drug

by Selina McKee | Sep 20, 2016 | News | 0

The US Food and Drug Administration has granted a conditional approval to Sarepta’s Exondys 51, the first drug cleared to treat patients with Duchenne muscular dystrophy (DMD).